| 7:45 AM-8:45 AM |
Keynote Address: Current Strategies for the Prevention and Management of Cardiometabolic Complications in People With Diabetes
Description:1. Describe how early prevention, identification and treatment of diabetes and cardiometabolic disease will improve patient outcomes through reducing risk and progression of microvascular and macrovascular complications.
2. Recognize the various components of cardiometabolic disease and understand how to utlize non-pharmacologic and pharmacologic strategies to effectively manage cardiometabolic risk and disease in diabetic diabetes.
Freny Vaghaiwalla Mody, MD,
Chief, Cardiology Division,
VA Greater Los Angeles Healthcare System,
Los Angeles, CA, Professor of Medicine,
David Geffen School of Medicine at UCLA,
Los Angeles, CA
|
| 8:45 AM-9:30 AM |
Use of Diagnostic and Screening Tools to Identify Patients With or at Increased Risk for Diabetes
Description:1.Identify & increase the use of tools for screening, diagnosing, monitoring and better managing diabetic patients and their comorbidities.
2. Describe 5 preventive measures for diabetes and the potential impact on the reducing A1C levels and associated cardiovascular risks
Anne Peters, MD,
Director,
USC Clinical Diabetes Programs,
Professor,
USC Keck School of Medicine,
USC Westside Center for Diabetes,
Los Angeles, CA
|
| 9:45 AM-10:45 PM |
The First Step: Managing Diabetic Hyperglycemia With Therapeutic Lifestyle Changes and Education
Description:1. Understand primary approaches to the effective management of recently diagnosed patients with diabetes and the how non-pharmacologic and pharmacologic strategies can provide improved glycemic control and reduce cardiometabolic risk.
2. Develop skills to overcome patient and cultural barriers by successfully educating patients to aggressively manage their disease while providing on-going support to prevent and better manage their diabetes.
Sue McLaughlin, RD, CDE, BS ,
Adjunct Professor,
Staff,
The Nebraska Medical Center,
Omaha, NE
|
| 10:45 AM-12:00 PM |
The Second Step: Progression of Treatment with Initial Oral Antihyperglycemic Agents and Combination Therapy
Description:1. Describe the cumulative effect of using multiple non-insulin agents to treat diabetic patients and how their combined use can impact overall glycemic management and cardiovascular risk.
2. Name 3 combination drug regimens, when to specifically initiate treatment, and their role in improving glucose control through adherence to guidelines.
Anthony L. McCall, MD, PhD, FACP,
James M. Moss Professor of Diabetes,
Diabetes & Hormone Center of Excellence,
UVA Health System,
Charlottesvle, VA
|
| 12:10 PM-1:10 PM |
Working Lunch: The Role of Incretin-Based Therapies in the Management of Diabetic Hyperglycemia
Description:1. Realize the utility of incretin-based therapies through understanding incretin glucoregulatory pathophysiology and mechanisms of action as a monotherapy or in combination with other non-insulin agents to better control glycemia.
2. Describe 2 classes of incretin-based therapies, their benefits and risks to use, and how they can be implemented in patient-specific scenarios to improve glycemic levels according to guidelines.
Richard E Pratley, MD,
Professor of Medicine,
University of Vermont College of Medicine,
Burlington, VT
|
| 1:20 PM-2:05 PM |
Insulin Therapy: Best Practices
Description:1. Describe 3 specific methods to overcome patient and/or clinician barriers to utilizing insulin and ensuring adherence to the therapeutic regimen
2. Differentiate commercially available insulin preparations and how to implement patient-specific insulin therapy to improve glycemic control and achieve glycemic targets
3. Discuss the benefits of combining insulin with non-insulin OADs therapies, its use, risks, and how a step-wise implementation of insulin will improve glycemic control in type 2 diabetic patients
James R. Gavin, III, MD, PhD,
Clinical Professor of Medicine,
Senior Health Advisor on Health Affairs,
Emory University School of Medicine,
Atlanta, GA
|
| 2:05 PM-3:05 PM |
Case-Based Workshop: Effective Use of Insulin
Description:1. Describe how to appropriately initiate insulin, intensify and how to change dosing based on type of insulin, glucose log, carbohydrate counting, and estimated exercise/activity.
2. Understand patient case-based examples of how to effectively utilize insulin while preventing urgent and emergent problems from developing
James R. Gavin, III, MD, PhD,
Clinical Professor of Medicine,
Senior Health Advisor on Health Affairs,
Emory University School of Medicine,
Atlanta, GA
|
| 3:15 PM-3:45 PM |
Managing Hypertension in Diabetic Patients
Description:1. Recognize the association between insulin resistance and cardiovascular disease in patients with diabetes and which drug combinations for blood pressure and glycemic control work best.
2. Recognize the relationship between metabolic syndrome and CVD and identify the earlier manifestations of microvascular / macrovascular hypertension while understanding optimal ways to effectively manage.
Michael J. Bloch, MD,
Associate Professor,
Department of Internal Medicine,
University of Nevada School of Medicine,
Reno, NV, Medical Director,
Risk Reduction Center,
Co-Director,
Vascular Institute,
St. Mary's Regional Medical Center,
Reno, NV
|
| 3:45 PM-4:15 PM |
Managing Dyslipidemia in Diabetic Patients
Description:1. Understand and outline the pleiotropic effects of dyslipidemia therapies (i.e.; statins, fibrates, omega 3s, bile acid sequestrants, etc) as a viable clinical intervention in the areas of CHD and CV risk, and become competent in the initiation and utilization of patient specific management strategies
2.Understand the complexity of hypertriglyceridemia and non-HDL-C, the importance or effective management and its potential impact on cardiovascular outcomes for your diabetic patients.
Michael J. Bloch, MD,
Associate Professor,
Department of Internal Medicine,
University of Nevada School of Medicine,
Reno, NV, Medical Director,
Risk Reduction Center,
Co-Director,
Vascular Institute,
St. Mary's Regional Medical Center,
Reno, NV
|
| 4:15 PM-5:30 PM |
Team Approaches to Managing Diabetic Complications and Comorbidities: Obesity, Depression, Sleep Apnea, Diabetic Foot
Description:1. Understand the important implications that Obesity, Depression, Sleep Apnea, Foot complications have on the diabetic patient and ways in which one can both effectively prevent, diagnose and treat these clinical concerns.
2. Identify & understand effective practice tools to better assess and manage the complexities of the diabetic patient, as well as educate patients in ways to prevent and recognize complications before they progress to negatively impact health.
Frank Lavernia, MD,
Founder,
North Broward Diabetes Center,
Pompano Beach, FL
Michael E. Cobble, MD,
Director,
Canyons Medical Center,
Sandy, UT
|
